During the past decade, Local hospital at the station Smolensk OAO RZD conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Local hospital at the station Smolensk OAO RZD" are "Ankylosing Spondylitis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Local hospital at the station Smolensk OAO RZD" in a lesser frequency.

Most popular intervention types in "Local hospital at the station Smolensk OAO RZD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Infliximab (BCD-055)" (1 trials), "Infliximab (Remicade)" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Local hospital at the station Smolensk OAO RZD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Local hospital at the station Smolensk OAO RZD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Local hospital at the station Smolensk OAO RZD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Local hospital at the station Smolensk OAO RZD, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".